BRK-B vs INTR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Inter & Co presents a stark contrast between strong growth metrics and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the company exhibits impressive revenue growth (26.4%) and earnings growth (35.5%), the low F-Score suggests significant internal financial instability or declining efficiency. The stock is attractively valued with a Forward P/E of 7.61 and trades well below its growth-based intrinsic value of $17.11, but this is offset by a bearish technical trend and poor insider sentiment. Overall, the growth potential is high, but the underlying financial health risks necessitate a neutral stance.
Compare Another Pair
Related Comparisons
BRK-B vs INTR: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Inter & Co, Inc. (INTR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.